Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma
Authors:
- 19 June 2018
- journal article
- research article
- Published by Springer Nature in La radiologia medica
- Vol. 123 (11) , 871-878
Abstract
Stereotactic body radiotherapy (SBRT) is emerging as a novel treatment option in metastatic soft tissue sarcoma (STS). The aim of our study was to evaluate the effectiveness of exclusive SBRT on disease control and survival in oligometastatic (≤ 3 synchronous lesions) STS.Keywords
This publication has 22 references indexed in Scilit:
- Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcomaThe Journal of Thoracic and Cardiovascular Surgery, 2017
- Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?Current Treatment Options in Oncology, 2017
- Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas.2015
- Safety and Efficacy of Stereotactic Body Radiation Therapy in the Treatment of Pulmonary Metastases from High Grade SarcomaSarcoma, 2013
- The CyberKnife radiosurgery system for lung cancerExpert Review of Medical Devices, 2012
- Stereotactic radiosurgery for primary and metastatic sarcomas involving the spineJournal of Neuro-Oncology, 2012
- The Radiation Response of Sarcomas by Histologic Subtypes: A Review With Special Emphasis Given to Results Achieved With RazoxaneSarcoma, 2006
- Repopulation of cancer cells during therapy: an important cause of treatment failureNature Reviews Cancer, 2005
- Postoperative Nomogram for 12-Year Sarcoma-Specific DeathJournal of Clinical Oncology, 2002
- Pulmonary Metastases From Soft Tissue SarcomaAnnals of Surgery, 1999